window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : March 4, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

automation

  • Clinical Development,Clinical studies,Clinical Trials,Data Management,Digital Health,Drug Development,Regulatory Affairs,Technology and platforms

    CluePoints: how proactive oversight and AI are reshaping clinical trial data management

    Dan Beaudry, market owner for risk-based quality management (RBQM) at [...]

    January 7, 2026
  • Facilities and infrastructure,Logistics and distribution,Market Access & Commercialization,Packaging

    Tjoapack expands US site to bolster packaging capacity and cold chain capabilities

    Tjoapack is expanding its US operations with a major build [...]

    December 10, 2025
  • Genomics and sequencing,Partnerships & Funding,Single Cell analysis,Technology and platforms

    SPT Labtech and Alithea Genomics partner to automate ultra sensitive single-cell RNA sequencing

    SPT Labtech has partnered with Alithea Genomics to automate single-cell [...]

    November 6, 2025
  • Artificial Intelligence,Biotech,CDMOs & Manufacturing

    Pharma leaders on AI, automation, and ESG: How CDMOs are reshaping development at CPHI Frankfurt 2025

    At another of this year’s CPHI Frankfurt 2025 roundtable, executives [...]

    November 6, 2025
  • Genomics and sequencing,Research & Development

    SPT Labtech and Agilent launch automated target enrichment workflows for genomic sequencing

    SPT Labtech and Agilent Technologies have introduced automated target enrichment [...]

    January 26, 2026
  • Cell & Gene Therapy,Medical devices,Movers & Shakers,Partnerships & Funding,Pharmaceuticals and therapeutics,Technology and platforms

    Robots could slash cost of cell therapy by 74%, opening doors to wider access

    Multiply Labs and Universal Robots pioneer automated manufacturing for personalised [...]

    August 25, 2025
  • Artificial Intelligence,Biologics & Biosimilars,CDMOs & Manufacturing,Market Access & Commercialization,Research & Development

    Nearly three-quarters of scientists expect a recession – but most still plan to spend LINUS survey reveals

    Despite political and economic pressures, researchers remain focused on collaboration, [...]

    July 31, 2025
  • Artificial Intelligence,Technology and platforms

    Retab launches developer-first document AI platform and raises $3.5M in pre-seed funding

    Retab, a startup aiming to simplify document automation for developers, [...]

    July 30, 2025
  • Artificial Intelligence,Biologics & Biosimilars,CDMOs & Manufacturing,Partnerships & Funding,Research & Development,Technology and platforms

    AI-powered bioreactor project aims to transform biologics manufacturing

    A Canada–UK collaboration is developing an AI-driven bioreactor platform designed [...]

    July 25, 2025
  • Drug Development,Research & Development,Technology and platforms

    Sygnature Discovery upgrades high-throughput chemistry platform following £1 million investment

    Sygnature Discovery has completed a major upgrade of its high-throughput [...]

    July 23, 2025
12Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Study confirms Nerivio REN wearable safe with continuous glucose monitoring devices
    Categories: Clinical studies, Digital Health, Drug Delivery & Formulation, Neurosciences
  • Promatix shows 50-fold potency in colorectal cancer with PBS293 ADC
    Categories: Biotech, Drug Development, Drug discovery, Oncology
  • SolasCure phase 2 trial shows faster healing in venous leg ulcers
    Categories: Clinical Trials, Dermatology, Drug Development
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top